Review



nbp1 32440 antibody  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Novus Biologicals nbp1 32440 antibody
    Nbp1 32440 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm42011738-106-9-7?v=Novus+Biologicals
    Average 92 stars, based on 10 article reviews
    nbp1 32440 antibody - by Bioz Stars, 2026-07
    92/100 stars

    Images



    Similar Products

    86
    Cell Marque pax8
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Pax8, supplied by Cell Marque, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/bio_rxiv__64898__2026__04__25__720834-213-12-13?v=Cell+Marque
    Average 86 stars, based on 1 article reviews
    pax8 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    92
    Novus Biologicals nbp1 32440 antibody
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Nbp1 32440 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm42011738-106-9-7?v=Novus+Biologicals
    Average 92 stars, based on 1 article reviews
    nbp1 32440 antibody - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    92
    Novus Biologicals pax8
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Pax8, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm42011738-106-1-7?v=Novus+Biologicals
    Average 92 stars, based on 1 article reviews
    pax8 - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    94
    OriGene pax8
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Pax8, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm41882597-70-53-55?v=OriGene
    Average 94 stars, based on 1 article reviews
    pax8 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory pax8 cre
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Pax8 Cre, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/bio_rxiv__64898__2026__03__20__713224-285-4-6?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    pax8 cre - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    Proteintech antigen retrieval
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Antigen Retrieval, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm41845519-76-18-22?v=Proteintech
    Average 96 stars, based on 1 article reviews
    antigen retrieval - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Proteintech pax8
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Pax8, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/pm41845519-76-20-22?v=Proteintech
    Average 96 stars, based on 1 article reviews
    pax8 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti pax8
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Rabbit Anti Pax8, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/bio_rxiv__64898__2026__03__11__710917-411-19-23?v=Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti pax8 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Proteintech guinea pig anti foxa1
    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. <t>Anti-PAX8</t> staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.
    Guinea Pig Anti Foxa1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pax8/bio_rxiv__64898__2026__03__11__710917-411-25-23?v=Proteintech
    Average 96 stars, based on 1 article reviews
    guinea pig anti foxa1 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. Anti-PAX8 staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.

    Journal: bioRxiv

    Article Title: Systems serology of responses against tumor antigens in ovarian cancer reveal disrupted Fc-mediated immunity

    doi: 10.64898/2026.04.25.720834

    Figure Lengend Snippet: A) Anti-human IgG (left) immunohistochemistry (IHC) staining of an HGSOC primary solid tumor specimen from patient 9. Anti-PAX8 staining (right) is included as a tumor-specific lineage marker. Scale bars represent 50 µm or 100 µm, where noted. B) Anti-human IgG (top) IHC staining of an HGSOC ascites specimen from patient 56. Anti-PAX8 staining (bottom) of the same ascites specimen from patient 56. Scale bars represent 50 µm or 100 µm, where noted. C) Quantification of the staining across patients with available samples in the cohort (n=29). Samples with heterogeneous staining were assigned a range instead of a single score. D) Visual depiction of our hypothesis. While TBAs bind to tumor cells, their Fc properties may prevent interaction with the FcγRs on immune cells. E) The ratio of FcγRIIIa to FcγRIIa binding across patients, separated by Ab antigenic target (n=61). Fluorescence is indicated by relative fluorescence units (RFU). In E), significance was determined between the TBAs and anti-viral Abs using a Kruskal-Wallis H Test followed by Dunn’s post-hoc test with Bonferroni corrections. Here, “*” and “**” represent p-values of less than 0.05 and 0.0005, respectively. See also Figure S1 and Table S1.

    Article Snippet: Sections were incubated in blocking buffer and stained with the following antibodies: PAX8 (Cell Marque #363M-15) and IgG (Dako #GA512).

    Techniques: Immunohistochemistry, Staining, Marker, Binding Assay, Fluorescence